MIT-Harvard Center of Cancer Nanotechnology Excellence
Massachusetts Institute of Technology and Harvard University
The goal of the MIT-Harvard Center of Cancer Nanotechnology Excellence is to better control and manipulate emerging new materials by precisely configuring molecular structures, adding biological functionalities, decreasing or eliminating toxicities, and creating novel designs for targeted drug and siRNA delivery, diagnostics, non-invasive imaging, and molecular sensing for better diagnosis and treatment of melanoma, prostate, and colon cancer.
Robert Langer, Sc.D.
Ralph Weissleder, M.D., Ph.D.
- Project 1: Targeted Nanoparticles for Tempospatially Controlled Combination Chemotherapy
- Project 2: Nanoformulations for siRNA Delivery to Ovarian Cancer
- Project 3: Magnetic Nanoparticles for Cellular Analysis
- Project 4: Discrete Sensor Devices for Determining Cancer Targets
- Project 5: Nanomaterial-Based Approaches for Early Detection of Metastasis
- Core A: Bioinformatics, Computation, and Image Analysis
- Core B: Animal Models/ Small Animals Imaging
- Core C: Nanomaterials Fabrication/ Synthesis and Characterization